Tag: metformin
Articles
- Does type 2 diabetes increase the risk of breast cancer?
- Latest research concerning triple negative breast cancer prognosis
- Latest research on factors influencing Adriamycin (doxorubicin) effectiveness
- Triple negative breast cancer
- Would fasting during chemotherapy improve treatment effectiveness?
News
- Diabetes and obesity increase breast cancer risk
- Metformin improves survival of diabetic women with HER2+ breast cancer
- Metformin might increase the effectiveness of radiation treatment by killing cancer stem cells
- Metformin might reduce growth of breast cancer in postmenopausal obese women
- Metformin reduces breast cancer development and growth in presence of high calorie diet
- Metformin reduces breast cancer risk in women with type 2 diabetes
- Metformin reduces cancer proliferation, but only in those with insulin resistance
- Metformin reduces risk of ER+/PR+ breast cancer in postmenopausal women
- Metformin suppresses metastasis of triple negative breast cancer cells
- The type 2 diabetic drug metformin should be considered as breast cancer treatment
- Women with high BMI may benefit less from hormonal treatments
Studies
- Breast Cancer among Patients with Diabetes, Obesity and Abnormal Blood Lipids - A Population-Based Register Study in Sweden
- Diabetes and Obesity Increase Risk for Breast Cancer Development
- Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy
- Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial
- Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer
- Eradicating cancer stem cells by targeting mTOR pathway with metformin
- Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial
- Metformin and breast cancer incidence in postmenopausal diabetic women in the Women’s Health Initiative (WHI)
- Metformin and Incident Breast Cancer among Diabetic Women: A Population-Based Case-Control Study in Denmark
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- Metformin and the mTOR Inhibitor Everolimus (RAD001) Sensitize Breast Cancer Cells to the Cytotoxic Effect of Chemotherapeutic Drugs In Vitro
- Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer
- Metformin enhances tumor regression and reduces tumor burden in a preclinical paradigm modeling obesity’s impact on postmenopausal breast cancer
- Metformin Induces a Dietary Restriction-Like State and the Oxidative Stress Response to Extend C. elegans Healthspan via AMPK, LKB1, and SKN-1
- Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
- Metformin reduces endogenous reactive oxygen species and associated DNA damage
- Metformin Represses Self-Renewal of the Human Breast Carcinoma Stem Cells via Inhibition of Estrogen Receptor-Mediated OCT4 Expression
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- Metformin: A Therapeutic Opportunity in Breast Cancer
- mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib
- Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions
- The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
- The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells